|
C16ORF63 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.212400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.496600E-01 |
| Normal-vs-Stage2 |
7.794000E-02 |
| Normal-vs-Stage3 |
2.163800E-02 |
| Normal-vs-Stage4 |
1.632050E-02 |
| Stage1-vs-Stage2 |
8.946400E-02 |
| Stage1-vs-Stage3 |
2.402200E-02 |
| Stage1-vs-Stage4 |
1.678390E-02 |
| Stage2-vs-Stage3 |
5.150400E-01 |
| Stage2-vs-Stage4 |
5.551900E-02 |
| Stage3-vs-Stage4 |
4.502100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.811760E-02 |
| Normal-vs-AfricanAmerican |
4.202800E-01 |
| Normal-vs-Asian |
7.823400E-01 |
| Caucasian-vs-AfricanAmerican |
2.855600E-01 |
| Caucasian-vs-Asian |
8.885600E-01 |
| AfricanAmerican-vs-Asian |
9.064400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.932400E-02 |
| Normal-vs-Female |
3.757900E-02 |
| Male-vs-Female |
3.707400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.762000E-01 |
| Normal-vs-Extreme_Weight |
6.204600E-01 |
| Normal-vs-Obese |
5.012300E-02 |
| Normal-vs-Extreme_Obese |
8.950400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.575400E-01 |
| Normal_Weight-vs-Obese |
7.358000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.874400E-01 |
| Extreme_Weight-vs-Obese |
1.508820E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.690400E-01 |
| Obese-vs-Extreme_Obese |
4.804200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.265200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.755920E-02 |
| Normal-vs-Age(61-80Yrs) |
2.660000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.049200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.744600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.422800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.957800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.087800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.481200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.812800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.849600E-01 |
| Normal-VS-Type2 PRCC |
6.398500E-02 |
| Normal-VS-KIRP CIMP |
9.361700E-03 |
| Normal-VS-Unclassified PRCC |
9.125900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.620370E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.015640E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.596780E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.577800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.532200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.027900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.230600E-01 |
| Normal-vs-N1 |
1.815760E-03 |
| Normal-vs-N2 |
5.621600E-01 |
| N0-vs-N1 |
7.259600E-03 |
| N0-vs-N2 |
7.179400E-01 |
| N1-vs-N2 |
3.297400E-01 |
|
|
